Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination

References

• DanaeiGFinucaneMMLuYGlobal Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose)National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participantsLancet2011378978531 4021705069
   PubMed Web of Science ®Google Scholar
• CDC, Department of Health and Human Services [homepage on the Internet]National diabetes statistics report2014 [updated 2014; cited May 15, 2015]. Available from: http://www.cdc.gov//diabetes/pubs/statsreport14/national-diabetes-report-web.pdfAccessed September 28, 2014
   Google Scholar
• StumvollMGoldsteinBJvan HaeftenTWPathogenesis of type 2 diabetesEndocr Res2007321–219 3718271503
   PubMed Web of Science ®Google Scholar
• KroonLAWilliamsCDiabetes mellitusAlldredgeBKCorelliRLErnstMEKoda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs10thPhiladelphia, PALippincott William and Wilkins20131223
   Google Scholar
• PietteJDHeislerMWagnerTHProblems paying out-of-pocket medication costs among older adults with diabetesDiabetes Care2004272384 39114747218
   PubMed Web of Science ®Google Scholar
• RubinRRAdherence to pharmacologic therapy in patients with type 2 diabetes mellitusAm J Med2005118Suppl 5A27S 34S15850551
   PubMed Web of Science ®Google Scholar
• JhaAKAubertREYaoJTeagardenJREpsteinRSGreater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annuallyHealth Aff (Millwood)20123181836 184622869663
   PubMed Web of Science ®Google Scholar
• BangaloreSKamalakkannanGParkarSMesserliFHFixed-dose combinations improve medication compliance: a meta-analysisAm J Med20071208713 71917679131
   PubMed Web of Science ®Google Scholar
• HutchinsVZhangBFleurenceRLKrishnarajahGGrahamJA systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetesCurr Med Res Opin20112761157 116821466277
   PubMed Web of Science ®Google Scholar
• PrescottJManaloBConsiderations for fixed-dose combination productes in cardiometabolic diseasePharmacy Times [serial on the Internet] [updated December 12, 2011; cited May 15, 2015]. Available from: http://www.pharmacytimes.com/publications/issue/2011/December2011/Considerations-for-FixedDose-Combination-Products-in-Cardiometabolic-DiseaseAccessed February 23, 2015
   Google Scholar
• Truven Health Analytics, IncClass Comparison: Antidiabetic Agents. Drug Consults. Micromedex 2.0Greenwood Village, COTruven Health Analytics, Inc.2015
   Google Scholar
• FDA approves invokametDrugs.com [homepage on the Internet] [updated August 8, 2014; cited May 15, 2015]. Available from: http://www.drugs.com/newdrugs/fda-approves-invokamet-canagliflozin-metformin-type-2-diabetes-4068.htmlAccessed February 13, 2015
   Google Scholar
• Invokamet [package insert]Titusville, NJJanssen Pharmaceuticals2014
   Google Scholar
• NigroSCRicheDMPhengMBakerWLCanagliflozin, a novel SGLT2 inhibitor for treatment of type 2 diabetesAnn Pharmacother201347101301 131124259694
   PubMed Web of Science ®Google Scholar
• ShaSDevineniDGhoshACanagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjectsDiabetes Obes Metab2011137669 67221457428
   PubMed Web of Science ®Google Scholar
• DevineniDCurtinCAriyawansaJBioequivalence of canagliflozin/metformin immediate release fixed- dose combination tablets compared with concomitant administration of single components of canagliflozin and metformin in healthy fed participantsJ Bioequiv Availab20146164 173
   Google Scholar
• StenlöfKCefaluWTKimKAEfficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exerciseDiabetes Obes Metab2013154372 38223279307
   PubMed Web of Science ®Google Scholar
• DeFronzoRAGoodmanAMEfficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The multicenter metformin study groupN Engl J Med19953339541 5497623902
   PubMed Web of Science ®Google Scholar
• CefaluWTLeiterLAYoonKHEfficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trialLancet20133829896941 95023850055
   PubMed Web of Science ®Google Scholar
• Lavalle-GonzálezFJJanuszewiczADavidsonJEfficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trialDiabetologia201356122582 259224026211
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationApproaches to glycemic treatmentDiabetes Care201538SupplS41 S4825537707
   PubMed Web of Science ®Google Scholar
• QiuRCapuanoGMeiningerGEfficacy and safety of twice-daily treatment with canagliflozin, A sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitusJ Clin Trans Endocri2014154 60
   Google Scholar
• JarabASAlmrayatRAlqudahSPredictors of non-adherence to pharmacotherapy in patients with type 2 diabetesInt J Clin Pharm2014364725 73324805800
   PubMed Web of Science ®Google Scholar
• LopezJMAnnunziataKBaileyRARupnowMFMoriskyDEImpact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherencePatient Prefer Adherence20148683 69224855344
   PubMed Web of Science ®Google Scholar
• SchernthanerGGrossJLRosenstockJCanagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trialDiabetes Care20133692508 251523564919
   PubMed Web of Science ®Google Scholar
• GarberAJAbrahamsonMJBarzilayJIAACE comprehensive diabetes management algorithm 2013Endocr Pract2013192327 33623598536
   PubMed Web of Science ®Google Scholar